Country - Belgium
Summary - Pharmaceutical Specialties Based On Eculizumab And Ravulizumab
Deadline - Sep 18, 2025
MT reference number - 114893974
Product classification - Pharmaceutical products
Address - Belgium
Contact details - 565656565
Tender notice no. - 76454545
MT Ref Id - 114893974
Document Type - Tender Notices
Description - Description: New patients will be subject to this public market, patients currently under treatment must not be changed. The doctor will keep the possibility of using the molecule best suited to the patient's needs.local title:: Spécialités pharmac eutiques à base de ECULIZUMAB et de RAVULIZUMABContract Duration: : 365 DAYContract Type: : Supplylocal description: : Les nouveaux patients feront l’objet de ce marché public, les patients actuellement sous traitement ne doivent pas obligatoirement en changer. Le médecin gardera la possibilité d’utiliser la molécule la mieux adaptée aux besoins du patient. lot_details: 1: Pharmaceutical specialty based on Eculizumab or Ravulizumab, 2:
Mt Ref Id - 114893974
Deadline - Sep 18, 2025
Similar Tenders :
Healthcare and Medicine